Literature DB >> 27316790

Role of Hypothalamic-Pituitary-Adrenal axis and corticotropin-releasing factor stress system on cue-induced relapse to alcohol seeking.

Fernanda L Galesi1, Lydia O Ayanwuyi2, Miriam Garcia Mijares1, Andrea Cippitelli2, Nazzareno Cannella2, Roberto Ciccocioppo2, Massimo Ubaldi3.   

Abstract

A large body of evidence has shown that the Corticotropin Releasing Factor (CRF) system, which plays a key role in stress modulation, is deeply involved in relapse to alcohol seeking induced by exposure to stressful events such as foot shock or yohimbine injections. Exposure to environmental cues is also known to be a trigger for alcohol relapse, nevertheless, the relationship between the relapse evoked by the cue-induced model and the CRF stress systems remains unclear. The purpose of this study was to evaluate, in male Wistar rats, the involvement of the CRF system and Hypothalamic-Pituitary-Adrenal (HPA) axis in relapse induced by environmental cues. Antalarmin, a selective CRF1 receptor antagonist, Metyrapone, a corticosterone (CORT) synthesis inhibitor and CORT were evaluated for their effects on the reinstatement test in a cue-induced relapse model. Antalarmin (20mg/kg) blocked relapse to alcohol seeking induced by environmental cues. Metyrapone (50 and 100mg/kg) also blocked relapse in Wistar rats but only at the highest dose (100mg/kg). Corticosterone had no effect on relapse at the doses tested. The results obtained from this study suggest that the CRF stress system and the HPA axis are involved in cue-induced alcohol relapse.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Addiction; Alcohol; CRF; Reinstatement; Relapse; Stress

Mesh:

Substances:

Year:  2016        PMID: 27316790      PMCID: PMC5028255          DOI: 10.1016/j.ejphar.2016.06.020

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  49 in total

1.  Locomotor suppressive and anxiolytic-like effects of urocortin 3, a highly selective type 2 corticotropin-releasing factor agonist.

Authors:  Glenn R Valdez; Eric P Zorrilla; Jean Rivier; Wylie W Vale; George F Koob
Journal:  Brain Res       Date:  2003-08-08       Impact factor: 3.252

2.  Update on corticotropin-releasing factor pharmacotherapy for psychiatric disorders: a revisionist view.

Authors:  George F Koob; Eric P Zorrilla
Journal:  Neuropsychopharmacology       Date:  2012-01       Impact factor: 7.853

3.  CP-154,526, a CRF type-1 receptor antagonist, attenuates the cue-and methamphetamine-induced reinstatement of extinguished methamphetamine-seeking behavior in rats.

Authors:  M C Moffett; N E Goeders
Journal:  Psychopharmacology (Berl)       Date:  2006-11-21       Impact factor: 4.530

4.  Glucocorticoids and behavioral effects of psychostimulants. II: cocaine intravenous self-administration and reinstatement depend on glucocorticoid levels.

Authors:  V Deroche; M Marinelli; M Le Moal; P V Piazza
Journal:  J Pharmacol Exp Ther       Date:  1997-06       Impact factor: 4.030

5.  Pharmacological blockade of corticotropin-releasing hormone receptor 1 (CRH1R) reduces voluntary consumption of high alcohol concentrations in non-dependent Wistar rats.

Authors:  Andrea Cippitelli; Ruslan Damadzic; Erick Singley; Annika Thorsell; Roberto Ciccocioppo; Robert L Eskay; Markus Heilig
Journal:  Pharmacol Biochem Behav       Date:  2011-10-20       Impact factor: 3.533

6.  Reinstatement of ethanol-seeking behavior by drug cues following single versus multiple ethanol intoxication in the rat: effects of naltrexone.

Authors:  Roberto Ciccocioppo; Daniel Lin; Rémi Martin-Fardon; Friedbert Weiss
Journal:  Psychopharmacology (Berl)       Date:  2003-03-27       Impact factor: 4.530

7.  Consequence of long-term exposure to corticosterone or dexamethasone on ethanol consumption in the adrenalectomized rat, and the effect of type I and type II corticosteroid receptor antagonists.

Authors:  C Fahlke; E Hård; C J Eriksson; J A Engel; S Hansen
Journal:  Psychopharmacology (Berl)       Date:  1995-01       Impact factor: 4.530

8.  Additive effect of stress and drug cues on reinstatement of ethanol seeking: exacerbation by history of dependence and role of concurrent activation of corticotropin-releasing factor and opioid mechanisms.

Authors:  Xiu Liu; Friedbert Weiss
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

9.  Combinations of oxazepam and metyrapone attenuate cocaine and methamphetamine cue reactivity.

Authors:  Courtney M Keller; Elyse M Cornett; Glenn F Guerin; Nicholas E Goeders
Journal:  Drug Alcohol Depend       Date:  2013-07-26       Impact factor: 4.492

10.  Involvement of corticosterone in the modulation of ethanol consumption in the rat.

Authors:  C Fahlke; J A Engel; C J Eriksson; E Hård; B Söderpalm
Journal:  Alcohol       Date:  1994 May-Jun       Impact factor: 2.405

View more
  4 in total

1.  Neuroendocrine response to GABA-B receptor agonism in alcohol-dependent individuals: Results from a combined outpatient and human laboratory experiment.

Authors:  Mehdi Farokhnia; Mikela B Sheskier; Mary R Lee; April N Le; Erick Singley; Sofia Bouhlal; Timmy Ton; Zhen Zhao; Lorenzo Leggio
Journal:  Neuropharmacology       Date:  2018-04-14       Impact factor: 5.250

2.  CB1 and ethanol effects on glutamatergic transmission in the central amygdala of male and female msP and Wistar rats.

Authors:  Dean Kirson; Christopher Shaun Oleata; Loren Howell Parsons; Roberto Ciccocioppo; Marisa Roberto
Journal:  Addict Biol       Date:  2017-06-28       Impact factor: 4.280

Review 3.  Corticotropin-Releasing Factor (CRF) Neurocircuitry and Neuropharmacology in Alcohol Drinking.

Authors:  Allyson L Schreiber; Nicholas W Gilpin
Journal:  Handb Exp Pharmacol       Date:  2018

4.  Glutamate attenuates lipopolysaccharide induced intestinal barrier injury by regulating corticotropin-releasing factor pathway in weaned pigs.

Authors:  Junjie Guo; Tianzeng Liang; Huifu Chen; Xiangen Li; Xiaorui Ren; Xiuying Wang; Kan Xiao; Jiangchao Zhao; Huiling Zhu; Yulan Liu
Journal:  Anim Biosci       Date:  2022-03-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.